In this episode of Interlinks, Patrick Daly speaks with Michael O’Kane, Strategic Business Consultant with Aramex Ireland, about the changing realities of life sciences supply chains in Ireland and beyond. Michael brings deep sector experience across pharma, biotech, medtech and advanced therapies, and shares his perspective on how Ireland has established itself as a critical node in the global life sciences network.
The conversation explores the operational backbone behind the sector: specialist logistics, cold chain management, regulatory compliance, technology adoption, and the growing need for seamless coordination across increasingly complex supply chains. Patrick and Michael also discuss the strategic partnership model between Aramex and Biocair, and how logistics providers are adapting to the specific demands of clinical and commercial life sciences flows.
Viewed through the macro-to-micro lens, this episode highlights a central reality for manufacturers and logistics partners alike: the practical challenges of compliance, regulation and product movement can no longer be managed in isolation from the wider geopolitical environment. As regulatory divergence, trade disruption, regional conflict and supply chain weaponisation reshape the global landscape, life sciences companies need to connect boardroom strategy with frontline operational execution. This discussion shows why resilience in healthcare supply chains now depends as much on geopolitical awareness as on technical and regulatory excellence.
","author_name":"Patrick Daly"}